The European Medicines Agency (EMA) has just issued conditional marketing authorization (CMA) for both Pfizer and BioNTech’s bivalent COVID-19 vaccines. The agency’s Committee for Medicinal Products for Human Use (CHMP) approved the vaccines as boosters for people 12 and up. These vaccines contain spike protein mRNA for the original SARS-CoV-2 virus and the BA.4/BA.5 Omicron strains currently dominant across the globe.
According to Emily Kimber, “If an authorisation is granted, doses of the booster will be available within the coming days to all 27 EU member states, supporting the start of the European vaccination campaigns. Local supply may vary based on individual country government requests, Pfizer outlined.”
To read more, click here.
(Source: PM Live, September 2nd, 2022)